Allurion Technologies Inc (ALUR)
1.86
-0.06
(-3.12%)
USD |
NYSE |
May 16, 16:00
1.88
+0.02
(+1.08%)
After-Hours: 20:00
Allurion Technologies Research and Development Expense (Quarterly): 6.071M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.071M |
| September 30, 2023 | 7.191M |
| June 30, 2023 | 6.581M |
| March 31, 2023 | 7.852M |
| Date | Value |
|---|---|
| December 31, 2022 | 5.732M |
| September 30, 2022 | 5.069M |
| June 30, 2022 | 3.096M |
| March 31, 2022 | 3.069M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
3.069M
Minimum
Mar 2022
7.852M
Maximum
Mar 2023
5.583M
Average
5.902M
Median
Research and Development Expense (Quarterly) Benchmarks
| Outset Medical Inc | 12.64M |
| Paragon 28 Inc | 7.584M |
| Perspective Therapeutics Inc | 6.08M |
| Xtant Medical Holdings Inc | 0.492M |
| Asensus Surgical Inc | 8.091M |